Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING

Issuer & Securities

Issuer/ Manager
HYPHENS PHARMA INTERNATIONAL LIMITED
Securities
HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5
Stapled Security
No

Announcement Details

Announcement Title
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast
05-Mar-2021 18:22:49
Status
New
Announcement Sub Title
CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING
Announcement Reference
SG210305OTHR2VWS
Submitted By (Co./ Ind. Name)
Lim See Wah
Designation
Executive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please refer to the attached Form 1.

This announcement has been prepared by the Company and its contents have been reviewed by the Sponsor for compliance with the Rules of Catalist. The Sponsor has not independently verified the contents of this press release.

This announcemen thas not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this press release.

The contact person for the Sponsor is Mr Kelvin Wong, Senior Vice President, who can be contacted at 12 Marina Boulevard, Level 46, Marina Bay Financial Centre Tower 3, Singapore 018982, Telephone: +65 6878 8888.

Additional Details

Person(s) giving notice
Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer
05/03/2021

Attachments

eFORM1V2 - TKK_050321_final.pdf
if you are unable to view the above file, please click the link below.
_eFORM1V2 - TKK_050321_final.pdf
Total size =150K